Hospital News and Research

RSS

Accuray, Lancaster announces commercial availability of InCise MLC for CyberKnife M6 System

Accuray Incorporated and Lancaster General Health announced today that the first commercially available InCise Multileaf Collimator (MLC) for the CyberKnife M6 System has been received by Lancaster.

24 Feb 2015

bioLytical receives FDA approval for INSTI HIV Antibody Test

bioLytical Laboratories Inc., a leading manufacturer of point-of-care rapid diagnostic tests, announced today that it has received U.S. Food and Drug Administration approval of its INSTI HIV Antibody Test for use in detecting antibodies to HIV type 2 (HIV-2).

24 Feb 2015

New NCCN Guidelines for treating Acute Lymphoblastic Leukemia

According to the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Acute Lymphoblastic Leukemia (ALL), the treatment approach to ALL is one of the most complex and intensive programs in cancer therapy.

24 Feb 2015

Epigenetics and women’s health research: an interview with Professor Steve Conlan, Swansea University

Our research into gynaecological oncology focuses around understanding mechanisms of how genes are regulated or how they become dysregulated in a disease; and also the effects that has on the surface of the endometrium and also the function of the ovaries...

From Chromatrap® - Porvair Sciences Ltd 24 Feb 2015

Study reveals how household net worth affects breast cancer care

Household net worth is a major and overlooked factor in adherence to hormonal therapy among breast cancer patients and partially explains racial disparities in quality of care. The findings suggest that physicians, health insurers, and policy makers need to pay more attention to this economic variable to ensure that breast cancer patients receive this potentially life-saving treatment.

24 Feb 2015

Johns Hopkins scientists identify genetic pathway that may spur cancer cell growth in children

Working with cells taken from children with a very rare but ferocious form of brain cancer, Johns Hopkins Kimmel Cancer Center scientists have identified a genetic pathway that acts as a master regulator of thousands of other genes and may spur cancer cell growth and resistance to anticancer treatment.

24 Feb 2015

Two widely used targeted therapy drugs not effective in preventing return of kidney cancer

Two widely used targeted therapy drugs— approved by the FDA for use in metastatic kidney cancer —are no more effective than a placebo in preventing return of the disease to increase life spans of patients suffering from advanced kidney cancer after surgery, according to new results to be presented by a researcher at the University of Pennsylvania's Abramson Cancer Center during the 2015 Genitourinary Cancers Symposium.

24 Feb 2015

RD Biomed to launch reflux diagnostic study in China

RD Biomed, the Hull-based medical technology company, will launch a study with over 1,000 patients in China to measure the effectiveness of its reflux diagnostic device Peptest.

24 Feb 2015

Boehringer Ingelheim presents Phase III data for tiotropium at 2015 AAAAI Annual Meeting

Boehringer Ingelheim today presented data on investigational tiotropium delivered via Respimat inhaler from five Phase III trials from the UniTinA-asthma program at the 2015 American Academy of Allergy, Asthma & Immunology Annual Meeting in Houston, Texas.

24 Feb 2015

MD Anderson researchers find way to predict patients who may respond to BRAF inhibitors

Powerful drugs known as BRAF-inhibitors have been crucial for melanoma patients, saving lives through their ability to turn off the BRAF protein's power to spur cancer cell growth.

24 Feb 2015

Tobacco smoke exposure common among children with bronchopulmonary dysplasia

Public health experts have long known that tobacco smoke exposure (TSE) can be harmful for children with bronchopulmonary dysplasia, a lung disease that often accompanies premature birth.

24 Feb 2015

Rogers Behavioral Health announces addition of eating disorder program to Tampa location

Rogers Behavioral Health-Tampa Bay announced today that it is adding a partial hospitalization eating disorder program to its Tampa location beginning March 30. This news is particularly timely as the nation recognizes National Eating Disorder Awareness Week February 22-28.

23 Feb 2015

NICE publishes Medtech Innovation Briefing on ZedScan

The NICE MIB has been developed on ZedScan as an adjunct to colposcopy in women with suspected cervical intra-epithelial neoplasia.

From Zilico 23 Feb 2015

NUS, Washington University jointly open new research institute to address social challenges

The National University of Singapore Faculty of Arts and Social Sciences has partnered the Washington University in St. Louis to set up a dedicated research institute - the Next Age Institute (NAI) - to study, design and test social innovations to address complex social issues surrounding families, communities and societies in Singapore and around the world.

23 Feb 2015

Nuo Therapeutics initiates phase 4 study of Aurix™ under CMS coverage with evidence development program

Nuo Therapeutics, Inc. (OTCQX:NUOT), a pioneer in biodynamic therapies, today announced the initiation of a new clinical study (Au Study) that is comprised of three randomized controlled protocols that examine the efficacy of Aurix™, a biodynamic hematogel, for use in diabetic foot ulcers, venous leg ulcers and pressure ulcers (bed sores).

23 Feb 2015

New HPV vaccine has potential to prevent 90% of conditions triggered by HPV

A new vaccine against HPV infections has the potential to prevent 90 per cent of all of the conditions triggered by the human papillomavirus. These are the findings of a randomised, controlled, international study involving a new, 9-component vaccine against HPV used on more than 14,000 young women aged between 16 and 26 years.

23 Feb 2015

Henry Ford researchers say that breastfeeding influences baby's immune system development

Henry Ford Hospital researchers say that breastfeeding and other factors influence a baby's immune system development and susceptibility to allergies and asthma by what's in their gut.

23 Feb 2015

CHLA pediatric expert answers questions about PTSD

PTSD. Four letters we immediately associate with soldiers and horrific wartime tragedies. But unfortunately, posttraumatic stress disorder (PTSD) can affect anyone who has experienced a traumatic event—including children with serious medical diagnoses.

23 Feb 2015

Beneficial effects of statin treatment exaggerated, say researchers

Hailed as miracle drugs when they hit the market two decades ago, statins, the cholesterol-lowering drugs prescribed to prevent heart attacks, are not as effective nor as safe as we have been led to believe, say Dr. David M. Diamond, a professor of psychology, molecular pharmacology and physiology at the University of South Florida, and Dr. Uffe Ravnskov, an independent health researcher and an expert in cholesterol and cardiovascular disease.

23 Feb 2015

VagiCap improves quality of life, satisfaction for postmenopausal women with vulvar and vaginal atrophy

Newly released patient satisfaction survey results from a study of a novel investigational vaginal estrogen treatment show promise for improving quality of life and satisfaction for postmenopausal women who experience pain during sex and other symptoms associated with vulvar and vaginal atrophy (VVA).

23 Feb 2015

Hospital News and Research

Accuray, Lancaster announces commercial availability of InCise MLC for CyberKnife M6 System

bioLytical receives FDA approval for INSTI HIV Antibody Test

New NCCN Guidelines for treating Acute Lymphoblastic Leukemia

Epigenetics and women’s health research: an interview with Professor Steve Conlan, Swansea University

Study reveals how household net worth affects breast cancer care

Johns Hopkins scientists identify genetic pathway that may spur cancer cell growth in children

Two widely used targeted therapy drugs not effective in preventing return of kidney cancer

RD Biomed to launch reflux diagnostic study in China

Boehringer Ingelheim presents Phase III data for tiotropium at 2015 AAAAI Annual Meeting

MD Anderson researchers find way to predict patients who may respond to BRAF inhibitors

Tobacco smoke exposure common among children with bronchopulmonary dysplasia

Rogers Behavioral Health announces addition of eating disorder program to Tampa location

NICE publishes Medtech Innovation Briefing on ZedScan

NUS, Washington University jointly open new research institute to address social challenges

Nuo Therapeutics initiates phase 4 study of Aurix™ under CMS coverage with evidence development program

New HPV vaccine has potential to prevent 90% of conditions triggered by HPV

Henry Ford researchers say that breastfeeding influences baby's immune system development

CHLA pediatric expert answers questions about PTSD

Beneficial effects of statin treatment exaggerated, say researchers

VagiCap improves quality of life, satisfaction for postmenopausal women with vulvar and vaginal atrophy

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

How microplastics and bacteria interact to drive antibiotic resistance

Single-cell proteomics: Revealing proteome diversity from cellular heterogeneity to non-canonical biology

Improving healthcare sustainability through carbon data

Latest News